Vaccine Maker Novavax Soars 150%

f?id=49f5be754b5437e1008e77d9&maxX=318&m

As we guessed, shares of small cap vaccine maker Novavax (NVAX) are going crazy this morning, soaring about 150% on the swinf flu news. That follows a 70% gain on Friday, so between the two days, you’re looking at a gain of over 400% since last Thursday.

Not bad.

Another one, Biocryst (BCRX) is up 90%, as it collects royalties from the sale of Tamiflu.

Now the question is: Can any of these companies actually turn a panic into a real business? For now, these companies are mainly going to appeal to traders.

Business Insider Emails & Alerts

Site highlights each day to your inbox.

Follow Business Insider Australia on Facebook, Twitter, LinkedIn, and Instagram.